Bicycle Therapeutics (BCYC) Announces Publication of Article Highlighting Preclinical Data of Tumor-Targeted Immune Cell Agonists in Journal for ImmunoTherapy of Cancer

Go back to Bicycle Therapeutics (BCYC) Announces Publication of Article Highlighting Preclinical Data of Tumor-Targeted Immune Cell Agonists in Journal for ImmunoTherapy of Cancer
(NASDAQ: BCYC) Delayed: 31.75 -0.02 (0.06%)
Previous Close $31.77    52 Week High
Open $32.68    52 Week Low
Day High $32.95    P/E N/A 
Day Low $30.50    EPS
Volume 96,533